RecruitingNCT05246579

Prospective Evaluation of Pathways for Preterm Birth

Prospective Evaluation of Pathways for Preterm Birth: The PEPP Study

Sponsor

John O'Brien, MD

Enrollment

240 participants

Start Date

Feb 4, 2022

Study Type

OBSERVATIONAL

Conditions

Preterm Birth Cervix; Pregnancy

Summary

This is a single center, prospective cohort study of pregnant patients at high risk for spontaneous preterm birth: patient's with history of spontaneous preterm birth, patient's with a short cervix and patient's symptomatic for preterm birth will be included. A control cohort of nulliparous patients without a short cervix will be recruited to provide baseline data. Plan to enroll 240 patients identified through our ultrasound unit with goal of 60 patients in each group.

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with cervix; pregnancy and preterm birth. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 45 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.